|
FAM179B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62936331093988E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05391259555654E-14 |
| Normal-vs-Stage2 |
1.95449989526253E-10 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.950000E-01 |
| Stage1-vs-Stage3 |
1.150230E-01 |
| Stage1-vs-Stage4 |
1.721810E-03 |
| Stage2-vs-Stage3 |
4.104100E-02 |
| Stage2-vs-Stage4 |
1.696910E-03 |
| Stage3-vs-Stage4 |
1.645810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6269208202857E-12 |
| Normal-vs-AfricanAmerican |
6.95109999560017E-08 |
| Normal-vs-Asian |
5.05151476204446E-14 |
| Caucasian-vs-AfricanAmerican |
3.860800E-01 |
| Caucasian-vs-Asian |
8.739000E-01 |
| AfricanAmerican-vs-Asian |
4.480200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99200722162641E-16 |
| Normal-vs-Female |
1.01030295240889E-14 |
| Male-vs-Female |
3.160400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.24344978758018E-14 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(81-100Yrs) |
2.11479999999709E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.948800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.633600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.122600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.753000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.855800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.742400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.800870E-04 |
| Classical-VS-Follicular |
1.195600E-01 |
| Classical-VS-Other |
7.131400E-01 |
| Classical-VS-Normal |
1.71107572555229E-12 |
| Tall-VS-Follicular |
4.4865000000005E-05 |
| Tall-VS-Other |
1.749180E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.407600E-01 |
| Follicular-VS-Normal |
2.22230012170144E-11 |
| Other-VS-Normal |
2.611400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64468438867971E-12 |
| Normal-vs-N1 |
9.99200722162641E-16 |
| N0-vs-N1 |
5.823600E-02 |
|
|
